Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,572 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
When a CHH executive exercises stock options and sells shares ahead of retirement, it can raise questions for investo...
CDL, the VictoryShares US Large Cap High Div Volatility Wtd ETF, continues to deliver a steady income stream with cdl...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
As Seer gears up for 2025 earnings, investors weigh growth, margins, and risk. This guide breaks down the drivers beh...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
Friday brought a sharp move for algonquin power utilities stock as investors digested a guidance miss for 2027. This ...
In a market that prizes glamor, some of the strongest performers hide in plain sight. This industrial stock could be ...
Market swings push many investors toward complexity. This article reveals a simple, cost-efficient core holding: a Va...
Looking ahead at geron (gern) 2026 earnings, this guide breaks down the catalysts, cash runway, and risks shaping the...